speaking of which, has there been any indication as to whether our end of March timeline for submitting the FDA data has been met? If not, would it be reasonable (but not a requirement I understand) that shareholders are updated? Bring ur investors along for the ride, share the pain and the gain…lack of information, not necessarily the missing of deadlines is what causes most investor angst…we do have a corporate media advisor don’t we?
Where we at?, page-111
-
- There are more pages in this discussion • 505 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.94M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 26.0¢ | $83.03K | 310.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 28731 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 3566 | 2 |
View Market Depth
| Last trade - 12.29pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |